CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Althoff, Keri N ^a   Gebo, Kelly A ^b   Gange, Stephen J ^a   Klein, Marina B ^c   Brooks, John T ^d   Hogg, Robert S ^e   Bosch, Ronald J ^f   Horberg, Michael A ^g   Saag, Michael S ^h   Kitahata, Mari M ⁱ   Eron, Joseph J ^j   Napravnik, Sonia ^j   Rourke, Sean B ^k   Gill, M John ^l   Rodriguez, Benigno ^m   Sterling, Timothy R ⁿ   Deeks, Steven G ^o   Martin, Jeffrey N ^o   Jacobson, Lisa P ^a   Kirk, Gregory D ^a   Collier, Ann C ⁱ   Benson, Constance A ^p   Silverberg, Michael J ^g   Goedert, James J ^q   McKaig, Rosemary G ^r   Thorne, Jennifer ^s   Rachlis, Anita ^t   Moore, Richard D ^b   Justice, Amy C ^u   more..

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e SIMON FRASER UNIVERSITY   (Canada)

^f HARVARD UNIVERSITY   (United States)

^g DIVISION OF RESEARCH   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF CALGARY   (Canada)

^m CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ VANDERBILT UNIVERSITY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^q NATIONAL CANCER INSTITUTE   (United States)

^r NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^s JOHNS HOPKINS UNIVERSITY   (United States)

^t UNIVERSITY OF TORONTO   (Canada)

^u YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANADA; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DEMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; UNITED STATES;

EID: 78650065934     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-7-45     Document Type: Article

References (28)

1. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010, 50:1512-1520. 10.1086/652650, 20415573.
2. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. US Department of Health and Human Services 2008, 1-139. Panel on Antiretroviral Guidelines for Adults and Adolescents.
3. Centers for Disease Control and Prevention Estimated percentage of new HIV infections by age - United States, 2006. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services 2009, Centers for Disease Control and Prevention.
4. Centers for Disease Control and Prevention HIV/AIDS Surveillance Report, 2006. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2008, 18. Centers for Disease Control and Prevention.
5. Luther VP, Wilkin AM. HIV infection in older adults. Clin Geriatr Med 2007, 23:567-83. vii, 10.1016/j.cger.2007.02.004, 17631234.
6. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys. Arch Intern Med 1994, 154:57-63. 10.1001/archinte.154.1.57, 8267490.
7. el-Sadr W, Gettler J. Unrecognized human immunodeficiency virus infection in the elderly. Arch Intern Med 1995, 155:184-186. 10.1001/archinte.155.2.184, 7811128.
8. Abel T, Werner M. HIV risk behaviour of older persons. Eur J Public Health 2003, 13:350-352. 10.1093/eurpub/13.4.350, 14703323.
9. Winningham A, Corwin S, Moore C, Richter D, Sargent R, Gore-Felton C. The changing age of HIV: sexual risk among older African American women living in rural communities. Prev Med 2004, 39:809-814. 10.1016/j.ypmed.2004.03.005, 15351550.
10. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007, 36:294-301. 10.1093/ije/dyl286, 2820873, 17213214.
11. Manfredi R, Calza L, Cocchi D, Chiodo F. Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly. J Acquir Immune Defic Syndr 2003, 33:112-114.
12. Viard JP, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 2001, 183:1290-1294. 10.1086/319678, 11262215.
13. Knobel H, Guelar A, Valldecillo G, Carmona A, Gonzalez A, Lopez-Colomes JL, et al. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 2001, 15:1591-1593. 10.1097/00002030-200108170-00025, 11505000.
14. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis 2003, 187:1924-1933. 10.1086/375372, 12792869.
15. Grabar S, Kousignian I, Sobel A, Le BP, Gasnault J, Enel P, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 2004, 18:2029-2038. 10.1097/00002030-200410210-00007, 15577624.
16. Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 2007, 167:684-691. 10.1001/archinte.167.7.684, 17420427.
17. Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Clin Infect Dis 2007, 45:654-657. 10.1086/520652, 17683004.
18. Collaboration of Observational HIV Epidemiologic Research Europe (COHERE) Study Group Response to combination antiretroviral therapy: variation by age. AIDS 2008, 22:1463-1473. 10.1097/QAD.0b013e3282f88d02, 18614870, Collaboration of Observational HIV Epidemiologic Research Europe (COHERE) Study Group.
19. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009, 360:1815-1826. 10.1056/NEJMoa0807252, 2854555, 19339714.
20. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999, 341:394-402. 10.1056/NEJM199908053410602, 10432324.
21. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342:921-929. 10.1056/NEJM200003303421303, 10738050.
22. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008, 22:2179-2185. 10.1097/QAD.0b013e328312c756, 2661869, 18832881.
23. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005, 39:446-453. 10.1097/01.qai.0000151079.33935.79, 16010168.
24. Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994, 169:28-36.
25. Hall HI, Geduld J, Boulos D, Rhodes P, An Q, Mastro TD, et al. Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr 2009, 51(Suppl 1):S13-S20.
26. Public Health Agency of Canada HIV and AIDS in Canada: Surveillance Report to December 31, 2006. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control 2007, Public Health Agency of Canada.
27. Public Health Agency of Canada HIV/AIDS Epi Updates, November 2007. Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 1-140 2007, Public Health Agency of Canada.
28. Torian L, Wiewel E. Risk factors for concurrent diagnosis fo HIV/AIDS in New York City, 2004: The role of age, transmission risk, and country of birth. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, California 2007,